about
Purification and cloning of PZR, a binding protein and putative physiological substrate of tyrosine phosphatase SHP-2Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifsIdentification and characterization of leukocyte-associated Ig-like receptor-1 as a major anchor protein of tyrosine phosphatase SHP-1 in hematopoietic cellsCD72 negatively regulates KIT-mediated responses in human mast cellsPinpointing phosphotyrosine-dependent interactions downstream of the collagen receptor DDR1Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signalingCD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1Identification of a family of Fc receptor homologs with preferential B cell expressionBiology and function of neuroimmune semaphorins 4A and 4DA double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signalsThe regulation of CD5 expression in murine T cellsPD-1 and its ligands are important immune checkpoints in cancerInhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatasesSHP-1 regulation of p62(DOK) tyrosine phosphorylation in macrophagesCloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis.Activation of Cdk2 stimulates proteasome-dependent truncation of tyrosine phosphatase SHP-1 in human proliferating intestinal epithelial cells.Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers.Apotosis of mature B cells.Characterization of the human B cell RAG-associated gene, hBRAG, as a B cell receptor signal-enhancing glycoprotein dimer that associates with phosphorylated proteins in resting B cells.SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines.PECAM-1 functions as a negative regulator of laminin-induced platelet activation.SHP2 mediates the localized activation of Fyn downstream of the α6β4 integrin to promote carcinoma invasion.Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain.Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family.Targeting dendritic cells for priming cellular immune responses.Cross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation.Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.LST1/A is a myeloid leukocyte-specific transmembrane adaptor protein recruiting protein tyrosine phosphatases SHP-1 and SHP-2 to the plasma membrane.DSHP: a "power bar" for sustained immune responses?Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells.The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytesA key tyrosine (Y1494) in the beta4 integrin regulates multiple signaling pathways important for tumor development and progression.CD5-mediated inhibition of TCR signaling proceeds normally in the absence of SHP-1Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1.Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.Redox regulation of T-cell receptor signaling.Epigenetic regulation in gallbladder cancer: Promoter methylation profiling as emergent novel biomarkers.
P2860
Q22004162-40AF6063-C324-4CCC-BE7E-0220B4EB3764Q22253219-50D6DBDF-DDE8-443C-8FFB-27B4D177023AQ22253887-5A9C2DDF-D961-419B-B329-BED88A831CC9Q24297400-FDC502B6-0018-4174-8220-4FF9B19E0D58Q24298387-5356D85C-3C4D-44F5-8DD7-25ED97810202Q24554273-AF16B08F-D16B-45D2-A121-1A46A07CB470Q24554515-2C9226EE-B9CE-4FD9-829E-3CCDDCF346F9Q24555760-06E57D46-7D3F-40E2-95FF-E1402DFC0A0EQ24612825-9069D0FC-59C1-487E-87D6-ED6F5A37E382Q24647322-812B5C90-47EA-4AF8-BE3A-32A80B2CC846Q24799307-F69ABD5D-5BA5-4747-A68B-E7D2090B9434Q28069485-6C18B3AB-2E9E-4AE7-814F-D53AA8BCEEDAQ28263470-CC37ED9C-8267-4B6C-A063-97EDAB40E872Q28593535-A1EC260E-7C4B-4BEA-8195-33FC8532EF61Q30669536-98478B58-FAF4-4178-B5F0-47E215C045FAQ31538849-01E81E6C-6F94-4B7E-B9B9-4843EFC8D354Q33350768-C0521C25-D8EE-41D5-951A-29ECB6876FD9Q33683386-703719A4-7F9B-4825-9438-48F42749EF90Q33811739-B309EA2E-D484-4EEE-ACE5-DCBFEB54D58DQ33896945-F1CF8204-E8EB-4734-8FD8-07C6FA64A91EQ33904273-9A7CEC12-302A-47B5-BE75-CA4670A4BDA9Q33950150-7E390994-A626-453A-BF57-54E71F46ADBAQ34002718-15822842-57D8-4EF1-AE17-1FA3DABC50C8Q34017429-EBA54CBE-84B6-40D4-A7D3-454A5465A731Q34290934-C8F42E98-6203-4EAF-8CFD-8CA182EB6305Q34776512-4DB33F0F-E633-4CE7-8545-AD34CB9EC10CQ35030968-77EB373E-F682-4048-8B27-7CCA53278E56Q35549421-F30B92CE-1700-483C-B2C8-132774CF7BF4Q35737263-5AA60DFB-DEBA-4A41-BA85-3C1705ACEB9AQ35958215-75D6F4F5-75B1-4ABA-BA10-4B46AEFB3DD6Q36080432-2C556E3B-2254-4815-8FDE-9CA0A99F4F99Q36081394-E6C06531-E527-4C3E-ADC4-E59C139608F8Q36330511-BF6ABA42-40A7-43B9-B769-E0D0AC27C1F0Q36385041-63F54F24-602A-4460-8AF3-70C9DFED635AQ36982557-513B8F1A-E603-48E7-85B0-1148B5CE6D00Q36983826-1A99A162-55D9-4672-8CE0-B2F48DD961D8Q37348839-C5D77554-230D-42CA-982A-12D2053A072BQ37628931-5B12929A-1C5C-4A78-B728-89ABA1CB65EEQ38381498-6ED38178-D409-49E3-8AD8-4C11AD9E7473Q38844664-A539E094-9A3E-4049-953D-229BE2B204F9
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Inhibitory receptors, ITIM sequences and phosphatases.
@en
type
label
Inhibitory receptors, ITIM sequences and phosphatases.
@en
prefLabel
Inhibitory receptors, ITIM sequences and phosphatases.
@en
P1476
Inhibitory receptors, ITIM sequences and phosphatases.
@en
P2093
P304
P356
10.1016/S0952-7915(97)80079-9
P577
1997-06-01T00:00:00Z